Latest From Biotech Now

U.S. Rep. Charlie Dent Discusses PDUFA and NIH Funding at #BIOCEO14

Dent

During the 16th Annual BIO CEO & Investor Conference, U.S. Representative Charlie Dent of Pennsylvania, co- chair of the Congressional Biomedical Research Caucus, joined BIO’s Fritz Bittenbender to discuss the biotech industry in Pennsylvania as well as recent legislative developments affecting the industry. Dent points to the recent omnibus spending agreement which allowed the Food and Drug Administration (FDA) to access user $85 million in user fees sequestered in 2013. These fees are paid to Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

The 2014 Farm Bill Becomes Law at MSU

farm-bill-signing-group-shot-115x76

The Lansing State Journal recently published an noteworthy editorial titled Allen Julian and Peter Pellerito: MSU a good site to sign Farm Bill. Allen Julian is the chief business officer of MBI International and Peter Pellerito is a senior policy Consultant at the Biotechnology Industry Organization. Both provide readers excellent insight to why Michigan was a fitting choice for the final signing of the 2014 Farm Bill: When President Obama toured the MBI facility and Read More >

Environmental & Industrial  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Why the Farm Bill is a Big Win for Biofuels

Erickson115x76

BIO‘s Brent Erickson, executive vice president of the industrial & environmental section, wrote a noteworthy op-ed titled “Some Good News for a Change: Why The Farm Bill Is a Big Win for Biofuels and Biorefineries.” Published in Biofuels Digest, Brent discusses how the passing of the 2014 Farm Bill was the much needed good news for the biofuels industry in light of the recent EPA’s proposed RVO rule as part of the 2014 Renewable Fuel Standard Read More >

Environmental & Industrial  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Immuno Oncology – A 30-year Overnight Success Story

Photo Feb 11, 1 30 16 PM

“It was the Rodney Dangerfield space – couldn’t get no respect” One would never guess those words were used to describe immuno-oncology, a field that has recently bloomed into full-fledged frenzy – with private companies raising unprecedented Series As, impressive data being announced and Science designating the field “Breakthrough of the Year” all in 2013. Yet Dr. Jeffrey Weber, an early member in the “i-onc” research community likened the past several decades of immuno-oncology to Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

The Economist – Biotechnology: Fever Rising

The-Economist-115x76

After speaking with several attendees and speakers at last week’s BIO CEO & Investor Conference, the Economist featured an article this week about the strong performance of biotech equities recently: AS INVESTORS and executives crammed into a New York ballroom for a conference held this week by the Biotechnology Industry Organisation, the mood was jittery. The previous week eight biotech firms had launched initial public offerings in America, together raising more than $500m. In a discussion Read More >

Business and Investments, Events  |  Leave a comment  |  Email This Post
Tags: , ,